Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic driver mutations.
11 employees · est. 2021 · Watertown, United States
Intra-Cellular Therapies
Developing innovative medicines for the treatment of neuropsychiatric and neurodegenerative diseases
759 employees · est. 2002 · New York, United States
Intra-Cellular Therapies is the older company (2021 vs 2002); Intra-Cellular Therapies is the larger of the two.
Side-by-Side Comparison
| Metric | Affini-T Therapeutics | Intra-Cellular Therapies |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2002 older |
| Headquarters | ||
| Headquarters | Watertown, United States | New York, United States |
| Employees | ||
| Employees | 11 | 759 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $175.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 1 | 9 |
| Services | ||
| Services | Developing specific TCR-based immunotherapies, Targeting oncogenic driver mutations, Conducting clinical trials and preclinical research | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Healthcare providers specializing in oncology, Research institutions, Pharmaceutical companies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Precision Immunotherapy, Oncogenic Driver Mutations, KRAS, Solid Tumor Therapies, T Cell Receptor (TCR) Therapy, Adoptive Cellular Therapy, Bispecific T Cell Engagers, Synthetic Biology, Gene Editing, Cancer Therapeutics, High-Affinity T Cell Receptors, Tumor Eradication, Proprietary Platforms, Cell Engineering, Biotechnology Innovation | Not tracked yet |
| Website | ||
| Website | affinittx.com | intracellulartherapies.com |
About Affini-T Therapeutics
Affini-T Therapeutics, founded in 2021, is a pioneering clinical-stage precision immunotherapy company headquartered in the United States. The company focuses on targeting oncogenic driver mutations, with an initial focus on KRAS, to create potentially curative therapies for patients with solid tumo...
About Intra-Cellular Therapies
Intra-Cellular Therapies, Inc. is a biopharmaceutical company founded on Nobel prize-winning research that allows it to understand how therapies affect the inner-workings of cells in the body. The Company leverages this intracellular approach to deliver innovative treatments for people living with c...
We will tell you when either one moves
BounceWatch watches Affini-T Therapeutics and Intra-Cellular Therapies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Affini-T Therapeutics and Intra-Cellular Therapi... — by email.
Frequently Asked Questions
Compare Affini-T Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Affini-T Therapeutics on 9 Jun 2026, and Intra-Cellular Therapies on 28 Oct 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.